Glycolipid and ganglioside metabolism imbalances in Huntington's disease
- 22 May 2007
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 27 (3) , 265-277
- https://doi.org/10.1016/j.nbd.2007.05.003
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Neurotrophic Enhancers as Therapy for Behavioral Deficits in Rodent Models of Huntington's Disease: Use of Gangliosides, Substituted Pyrimidines, and Mesenchymal Stem CellsBehavioral and Cognitive Neuroscience Reviews, 2006
- Regional and cellular gene expression changes in human Huntington's disease brainHuman Molecular Genetics, 2006
- Huntingtin Associates with Acidic Phospholipids at the Plasma MembraneJournal of Biological Chemistry, 2005
- Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic MiceCell, 1996
- Huntington's disease: translating a CAG repeat into a pathogenic mechanismCurrent Opinion in Neurobiology, 1996
- The localization of gangliosides in neurons of the central nervous system: the use of anti-ganglioside antibodiesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1996
- Characterization of Mouse ST8Sia II (STX) as a Neural Cell Adhesion Molecule-specific Polysialic Acid SynthaseJournal of Biological Chemistry, 1996
- Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neuronsNeuron, 1995
- Dysmyelinogenesis in animal model of GM1 gangliosidosisPediatric Neurology, 1992
- Composition of brain gangliosidesBiochimica et Biophysica Acta, 1961